FDA had released final guidance entitled “ANDA Submissions – Amendments and Requests for Final Approval to Tentatively Approved ANDAs” For details, please visit: https://www.fda.gov/media/119718/download

About CBCC Global Research

At CBCC Global Research, we are accelerating medical therapy development by providing high quality, affordable and innovative solutions.

We provide strategic solutions for all phases of clinical trials through efficient delivery of services for the flawless execution of projects, on time – every time.

We are committed to achieving excellence in all research projects by ensuring scientific validity, data integrity, and compliance with the latest regulatory guidelines, thus striving to be a leading global clinical research organization (CRO).